Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China flag China · Delayed Price · Currency is CNY
39.38
-0.67 (-1.67%)
Aug 14, 2026, 3:00 PM CST

SHA:600211 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
941.74937.931,051800.91369.84208.94
Depreciation & Amortization
87.8778.3475.268.0569.2481.45
Other Amortization
2.572.060.641.011.550.68
Loss (Gain) From Sale of Assets
0.04-0.11-1.96-0.340.230.04
Asset Writedown & Restructuring Costs
7.550.030.07190.38218.62458.19
Loss (Gain) From Sale of Investments
-10.54-4.153.88170.097.14-146.47
Provision & Write-off of Bad Debts
0.39-0.40.60.04-0.51-1.39
Other Operating Activities
6.23-14.87-12.63-5.6881.9415.93
Change in Accounts Receivable
85.05-195.4298.83-237.8922.82-317.1
Change in Inventory
-41.81-43.3-22.56-16.56-18.87-67.2
Change in Accounts Payable
-210.9225.41-163.73147.438.73164.85
Change in Other Net Operating Assets
6.680.372.021.8752.43-1.62
Operating Cash Flow
883.691,005994.791,063837.38366.53
Operating Cash Flow Growth
-11.66%1.00%-6.45%26.99%128.46%-14.39%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-13.59-15.96-37.6-21.69-101.96-425.58
Sale of Property, Plant & Equipment
0.130.342.780.540.1116.78
Cash Acquisitions
162.48162.48----
Investment in Securities
-820.46-757.91367.91-829.46-471.69-334.97
Other Investing Activities
26.3321.9721.3918.7212.32.97
Investing Cash Flow
-645.09-589.07354.49-831.88-561.25-740.8

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-980.11533.5699.51485.73-
Long-Term Debt Issued
-----576.54
Total Debt Issued
1,406980.11533.5699.51485.73576.54
Short-Term Debt Repaid
--502.19-760.97-685.73-534.27-
Long-Term Debt Repaid
--1.03-0.93-1.65-3.56-56.08
Total Debt Repaid
-1,024-503.22-761.9-687.39-537.82-56.08
Net Debt Issued (Repaid)
382.86476.89-228.412.13-52.09520.46
Common Dividends Paid
-576.87-613.53-504.05-494.47-98.18-132.49
Other Financing Activities
-145.9514.02-0.54-1.344.9-11.3
Financing Cash Flow
-339.95-122.62-732.99-483.69-145.37376.67

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-34.67-22.457.447.0440.11-14.42
Net Cash Flow
-136.03270.6623.72-245.11170.87-12.02

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
870.11988.79957.191,042735.41-59.05
Free Cash Flow Growth
-9.71%3.30%-8.12%41.65%--
Free Cash Flow Margin
30.16%33.16%34.10%33.24%28.79%-2.76%
Free Cash Flow Per Share
2.723.072.973.232.28-0.18
Levered Free Cash Flow
556.57697.85483.26585.86456.08-60.38
Unlevered Free Cash Flow
578.31705.72489.19593.11465.06-57.68

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
223.09392.38500.59443.23272.41274.84
Change in Working Capital
-152.165.92-122.3-161.0589.34-250.83